Sarepta Therapeutics, Inc. (SRPT)

16.23 +0.14 (+0.87%) USD  |  NASDAQ  |  Mar 05, 16:00
16.27 +0.04 (+0.25%) After-Hours: 17:21
More

Sarepta Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
REGENXBIO, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade